Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujun Cai

Showing results (271-280 of 299) with videos related to

Pageof 30
Sort By:
Clinical and Translational Gastroenterology|October 31, 2019
Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder LesionsMingyu Chen, Jiasheng Cao, Yang Bai, et al.
Nature Communications|September 14, 2023
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancerSarun Juengpanich, Shijie Li, Taorui Yang, et al.
Clinical and Molecular Hepatology|February 20, 2026
IL-1β as Target to Induce Synthetic Lethality in KRAS Mutant Biliary Tract CancerShijie Li, Yukai Shan, Tianen Chen, et al.
Cell Stem Cell|April 14, 2023
Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytesYifan Wang, Qiang Zheng, Zhen Sun, et al.
Cell|December 10, 2025
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapyYan Xu, Xiaoge Zhang, Xiao Han, et al.
Nature Communications|January 2, 2025
Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activationFubo Ji, Jianjuan Zhang, Liping Mao, et al.
Nature Communications|March 22, 2026
X-ray preactivated reversible persistent luminescence enables photodynamic immunotherapy of deep tumorsWin Topatana, Yuchao Sun, Tianao Xie, et al.
Liver Cancer|March 12, 2021
Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular CarcinomaMingyu Chen, Jiasheng Cao, Jiahao Hu, et al.
Science Bulletin|March 22, 2024
Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethalityShijie Li, Sarun Juengpanich, Win Topatana, et al.
Nature Communications|June 11, 2026
Natural killer cell-mediated immunosurveillance modulates liver cancer evolution through cancer stemness enhancement and lipid metabolism reprogrammingLiang Shi, Boqiang Liu, Ruya Sun, et al.
Pageof 30

Showing results (271-280 of 299) with videos related to

Sort By:
Pageof 30
Clinical and Translational Gastroenterology|October 31, 2019
Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder LesionsMingyu Chen, Jiasheng Cao, Yang Bai, et al.
Nature Communications|September 14, 2023
Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancerSarun Juengpanich, Shijie Li, Taorui Yang, et al.
Clinical and Molecular Hepatology|February 20, 2026
IL-1β as Target to Induce Synthetic Lethality in KRAS Mutant Biliary Tract CancerShijie Li, Yukai Shan, Tianen Chen, et al.
Cell Stem Cell|April 14, 2023
Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytesYifan Wang, Qiang Zheng, Zhen Sun, et al.
Cell|December 10, 2025
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapyYan Xu, Xiaoge Zhang, Xiao Han, et al.
Nature Communications|January 2, 2025
Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activationFubo Ji, Jianjuan Zhang, Liping Mao, et al.
Nature Communications|March 22, 2026
X-ray preactivated reversible persistent luminescence enables photodynamic immunotherapy of deep tumorsWin Topatana, Yuchao Sun, Tianao Xie, et al.
Liver Cancer|March 12, 2021
Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular CarcinomaMingyu Chen, Jiasheng Cao, Jiahao Hu, et al.
Science Bulletin|March 22, 2024
Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethalityShijie Li, Sarun Juengpanich, Win Topatana, et al.
Nature Communications|June 11, 2026
Natural killer cell-mediated immunosurveillance modulates liver cancer evolution through cancer stemness enhancement and lipid metabolism reprogrammingLiang Shi, Boqiang Liu, Ruya Sun, et al.
Pageof 30